Aroa Biosurgery Limited
AROAF
$0.40
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.63M | -5.53M | -6.49M | -5.79M | -5.08M |
| Total Depreciation and Amortization | 1.37M | 1.37M | 1.37M | 1.31M | 1.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.34M | 4.52M | 4.68M | 5.39M | 6.01M |
| Change in Net Operating Assets | -4.08M | -4.08M | -4.08M | -5.15M | -6.12M |
| Cash from Operations | -3.01M | -3.73M | -4.51M | -4.23M | -3.96M |
| Capital Expenditure | -1.81M | -1.97M | -2.15M | -2.92M | -3.64M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.56M | 9.91M | 8.33M | 5.87M | 3.43M |
| Cash from Investing | 9.74M | 7.94M | 6.18M | 2.95M | -209.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -847.00K | -793.50K | -740.00K | -725.50K | -711.00K |
| Issuance of Common Stock | 69.00K | 90.00K | 111.00K | 84.50K | 58.00K |
| Repurchase of Common Stock | -- | -- | -- | -15.00K | -30.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -421.00K | -413.00K | -405.00K | -241.00K | -77.00K |
| Cash from Financing | -729.30K | -677.10K | -630.90K | -548.70K | -465.90K |
| Foreign Exchange rate Adjustments | -142.40K | 2.00K | 148.30K | -73.80K | -286.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.87M | 3.54M | 1.19M | -1.90M | -4.93M |
